International Studies of Infarct Survival (ISIS)
4
First published: 15 July 2005
No abstract is available for this article.
References
- 1
ISIS-1 (First International Study of lnfarct Survival) Collaborative Group
(1986).
Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1,
Lancet
2,
57–65.
- 2
ISIS-2 (Second International Study of lnfarct Survival) Collaborative Group
(1998).
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2,
Lancet
2,
349–360.
- 3
ISIS-3 (Third International Study of lnfarct Survival) Collaborative Group
(1992).
ISIS-3: Randomised comparison of streptokinase vs. tissue plasminogen activator vs. anistreplase and of aspirin plus heparin vs. aspirin alone among 41299 cases of suspected acute myocardial infarction: ISIS-3.
Lancet
339,
75–70.
- 4
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group
(1995).
ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction: ISIS-4.
Lancet
345,
669–685.
